Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19

Medical University Innsbruck100 enrolled

Overview

The aim of this possible study is to identify if SARS-CoV-2 can be found in the tear film and conjunctiva of a patient with COVID-19.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

100

Conditions

COVID-19 SARS-CoV 2

Interventions

Conjunctival swab and nasopharyngeal swabDIAGNOSTIC_TEST

Both conjunctival swab and nasopharyngeal swab for SARS-COV 2 are conducted in patients with COVID-19.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥ 18 years * A confirmed COVID-19 disease * Signed and dated declaration of consent * The patient fell ill in Tyrol Exclusion Criteria: * none

Locations (1)

Medical University Innsbruck

Innsbruck, Tyrol, Austria

RECRUITING

Outcomes

Primary Outcomes

SARS-CoV2 positive conjunctival swabs

The primary endpoint is the number of conjunctival swabs tested positive for SARS-CoV2.

Time frame: 1 year

Secondary Outcomes

Conjunctival swab vs nasopharyngeal swab

The secondary target is the difference between the conjunctival swab tested positive for SARS-CoV2 and the nasopharyngeal swab.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.